Physician profile
Wayne Wei Kuang
NPI 1720043151
$127,749.49
in general payments reported to CMS, 2019-2025
20 companies · $28K in 2025
The $28K reported for 2025 was more than what 97% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23K · 2020: $26K · 2021: $16K · 2022: $16K · 2023: $1,135 · 2024: $17K · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Travel and Lodging: $4,103 · Food and Beverage: $2,525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,440.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,000.00 |
| Travel and Lodging | $4,102.86 |
| Food and Beverage | $2,525.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $43,250.82 | 2019-2020 | |
| Teleflex LLC | $31,885.54 | 2021-2022 | |
| Olympus America INC. | $28,253.94 | 2023-2025 | Itind System, Soltive, Soltive |
| Olympus Corporation of The Americas | $6,091.73 | 2024-2025 | Itind System |
| Srs Medical Systems, INC. | $5,161.62 | 2019-2024 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Sumitomo Pharma America, INC. | $5,102.38 | 2025 | Gemtesa |
| Hologic Sales and Service, LLC | $5,035.87 | 2024 | Myosure Tissue Removal Device |
| Cytyc Surgical Products, LLC | $1,080.66 | 2024 | Novasure, Acessa Provu System, None |
| Boston Scientific Corporation | $780.63 | 2019-2022 | |
| Astellas Pharma US INC | $259.55 | 2019-2021 | |
| Endo Pharmaceuticals INC. | $209.16 | 2019-2023 | Xiaflex, Aveed, Edex |
| Ferring Pharmaceuticals INC. | $164.86 | 2019 | |
| Procept Biorobotics Corporation | $162.87 | 2024-2025 | Aquabeam System |
| Laborie Medical Technologies Corp. | $113.88 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Endo USA, INC. | $88.42 | 2024-2025 | Xiaflex, Aveed |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $37.01 | 2025 | Altaviva |
| Medline Industries Lp | $22.90 | 2019 | |
| Coloplast Corp | $19.60 | 2019 | |
| Palette Life Sciences, INC. | $16.29 | 2021 | |
| Pfizer INC. | $11.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wayne Kuang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.